Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
Status:
Terminated
Trial end date:
2020-10-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of SHP647 in inducing remission, based
on composite score of participant-reported symptoms and centrally read endoscopy, in
participants with moderate to severe ulcerative colitis (UC).